Literature DB >> 34273348

Response to Rigel et al.

Michael A Marchetti1, Stephen W Dusza2.   

Abstract

Entities:  

Year:  2021        PMID： 34273348      PMCID： PMC8688182          DOI： 10.1016/j.jid.2021.06.023

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN： 0022-202X            Impact factor:   8.551


× No keyword cloud information.
  9 in total

1.  The Rapid Rise in Cutaneous Melanoma Diagnoses.

Authors:  H Gilbert Welch; Benjamin L Mazer; Adewole S Adamson
Journal:  N Engl J Med       Date:  2021-01-07       Impact factor: 91.245

2.  Real-World Utility of a Non-Invasive Gene Expression Test to Rule Out Primary Cutaneous Melanoma: A Large US Registry Study.

Authors:  Brook Brouha; Laura K Ferris; Maral K Skelsey; Gary Peck; Ronald Moy; Zuxu Yao; Burkhard Jansen
Journal:  J Drugs Dermatol       Date:  2020-03-01       Impact factor: 2.114

3.  Real-world performance and utility of a noninvasive gene expression assay to evaluate melanoma risk in pigmented lesions.

Authors:  Laura K Ferris; Pedram Gerami; Maral K Skelsey; Gary Peck; Catherine Hren; Christopher Gorman; Tana Frumento; Daniel M Siegel
Journal:  Melanoma Res       Date:  2018-10       Impact factor: 3.599

Review 4.  Atypical Melanocytic Proliferations: A Review of the Literature.

Authors:  Courtney J Ensslin; Brian P Hibler; Erica H Lee; Kishwer S Nehal; Klaus J Busam; Anthony M Rossi
Journal:  Dermatol Surg       Date:  2018-02       Impact factor: 3.398

5.  Economic Analysis of a Noninvasive Molecular Pathologic Assay for Pigmented Skin Lesions.

Authors:  John Hornberger; Daniel M Siegel
Journal:  JAMA Dermatol       Date:  2018-09-01       Impact factor: 10.282

6.  STARD 2015 guidelines for reporting diagnostic accuracy studies: explanation and elaboration.

Authors:  Jérémie F Cohen; Daniël A Korevaar; Douglas G Altman; David E Bruns; Constantine A Gatsonis; Lotty Hooft; Les Irwig; Deborah Levine; Johannes B Reitsma; Henrica C W de Vet; Patrick M M Bossuyt
Journal:  BMJ Open       Date:  2016-11-14       Impact factor: 2.692

7.  Development and validation of a noninvasive 2-gene molecular assay for cutaneous melanoma.

Authors:  Pedram Gerami; Zuxu Yao; David Polsky; Burkhard Jansen; Klaus Busam; Jonhan Ho; Mary Martini; Laura K Ferris
Journal:  J Am Acad Dermatol       Date:  2016-10-01       Impact factor: 11.527

8.  Pathologists' diagnosis of invasive melanoma and melanocytic proliferations: observer accuracy and reproducibility study.

Authors:  Joann G Elmore; Raymond L Barnhill; David E Elder; Gary M Longton; Margaret S Pepe; Lisa M Reisch; Patricia A Carney; Linda J Titus; Heidi D Nelson; Tracy Onega; Anna N A Tosteson; Martin A Weinstock; Stevan R Knezevich; Michael W Piepkorn
Journal:  BMJ       Date:  2017-06-28

9.  Net benefit approaches to the evaluation of prediction models, molecular markers, and diagnostic tests.

Authors:  Andrew J Vickers; Ben Van Calster; Ewout W Steyerberg
Journal:  BMJ       Date:  2016-01-25
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.